Skip to main content
    S

    Scotts Miracle-Gro Company (SMG)

    Official site

    BASIC MATERIALS • AGRICULTURAL INPUTS • NYSE

    $63.84
    +0.10 (+0.16%)

    Market Cap: $3.72B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Scotts Miracle-Gro Company (SMG) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Scotts Miracle-Gro Company (SMG) to earn $4.79 per share in the fiscal year ending Sep 30, 2027, on revenue of $3.38B. Of 8 analysts, 6 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Sep 30, 2027 were revised up and 3 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.13, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.

    RatingAnalystsShare
    Strong Buy112.5%
    Buy562.5%
    Hold225.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    8

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 8.4% and revenue estimates rise 2.4%.

    Fiscal year ending Sep 30, 2027
    $4.79
    EPS consensus, revenue $3.38B
    Fiscal year ending Sep 30, 2028
    $5.19
    EPS consensus, revenue $3.46B
    Next report
    Jan 26, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Sep 30, 2027$4.79$4.75 to $4.878$3.38B$3.36B to $3.40B8
    Sep 30, 2028$5.19$5.07 to $5.438$3.46B$3.43B to $3.51B8

    Quarterly Estimates

    The EPS consensus rises from -$0.97 for the quarter ending Dec 31, 2026 to $4.48 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.97-$1.18 to -$0.846$355.83M$338.00M to $372.00M6
    Mar 31, 2027$4.48$4.39 to $4.616$1.46B$1.46B to $1.47B6

    Estimate Revisions

    Across the 4 periods below, the last 30 days brought 8 upward and 9 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Sep 30, 202703
    Fiscal year ending Sep 30, 202831
    Quarter ending Dec 31, 202632
    Quarter ending Mar 31, 202723

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has risen 1.3% from $4.73.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Sep 30, 2027$4.79$4.69$4.70$4.73$4.73+1.3%
    Fiscal year ending Sep 30, 2028$5.19$5.16$5.13$5.20$5.10+1.9%
    Quarter ending Dec 31, 2026-$0.97-$0.72-$0.73-$0.72-$0.72N/A
    Quarter ending Mar 31, 2027$4.48$4.59$4.61$4.64$4.64-3.4%

    Frequently Asked Questions About SMG

    What is the SMG stock forecast?

    Consensus analyst estimates put Scotts Miracle-Gro Company's EPS at $4.79 for the fiscal year ending Sep 30, 2027, on revenue of $3.38B. The consensus rating from 8 analysts is Buy.

    How do analysts rate SMG stock?

    Of 8 analysts covering Scotts Miracle-Gro Company, 1 rates it Strong Buy, 5 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from SMG next year?

    For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is $4.79, with estimates from $4.75 to $4.87 from 8 analysts. For the fiscal year ending Sep 30, 2028, the consensus EPS estimate is $5.19, with estimates from $5.07 to $5.43 from 8 analysts.

    What revenue do analysts expect from Scotts Miracle-Gro Company next year?

    For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $3.38B, with estimates from $3.36B to $3.40B. For the fiscal year ending Sep 30, 2028, the consensus revenue estimate is $3.46B, with estimates from $3.43B to $3.51B.

    How many analysts cover SMG?

    8 analysts rate Scotts Miracle-Gro Company stock, and 8 analysts estimate its EPS for the fiscal year ending Sep 30, 2027.